Rapamycin: Friend, foe, or misunderstood?

This publication has 14 references indexed in Scilit:

• A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS
  Transplantation, 2001
• Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
  The Lancet, 2000
• Sirolimus-tacrolimus combination immunosuppression
  The Lancet, 2000
• Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation
  The Journal of Heart and Lung Transplantation, 1999
• Altered flow properties of blood and increased plasma fibrinogen in cyclosporin-treated renal allograft recipients
  Nephrology Dialysis Transplantation, 1999
• SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
  Transplantation, 1999
• SIROLIMUS: A POTENT NEW IMMUNOSUPPRESSANT FOR LIVER TRANSPLANTATION
  Transplantation, 1999
• Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression
  Clinical Biochemistry, 1998
• The effects of the immunosuppressant rapamycin on the growth of rheumatoid arthritis (RA) synovial fibroblast
  Clinical and Experimental Immunology, 1996
• THROMBOEMBOLIC COMPLICATIONS IN RENAL ALLOGRAFT RECIPIENTS A REPORT FROM THE PROSPECTIVE RANDOMIZED STUDY OF CYCLOSPORINE VERSUS AZATHIOPRINE-ANTILYMPHOCYTE GLOBULIN
  Transplantation, 1987